Fairmount Funds Management Portfolio
ActivistFairmount Funds Management LLC 13F holdings · Q3 2026 vs Q2 2026
Why activist: 12 holdings, 7 effective · top 10 98% · turnover 18% a quarter · earnings yield -4.0% (median 2.9%) · 23 Schedule 13D filings, 85% of the book · 28 quarters of 13Fs
- 13F value
- $1.6bn+5.4% vs $1.5bn in Q2 2026
- Holdings
- 10 1 new · 0 sold out
- Top 10 weight
- 85.1% Largest: ORKA 19.4%
- Bought est.
- $292m New positions and adds
- Sold est.
- $0 Trims and exits
- Quarter
- Q3 2026 Filed
Largest trades since Q2 2026
Estimated dollars: the change in shares times the quarter-end price the filing implies. Exits use last quarter's value.
| Action | Stock | Shares | Est. traded | Weight | Other gurus |
|---|---|---|---|---|---|
| New | KRSAKORSANA BIOSCIENCES INC | New | +$291m | 0.0% → 18.3% | 5 |
| Added | ZBIOZENAS BIOPHARMA INC | +0.5% | +$333k | 4.0% → 4.0% | 0 |
All holdings 10 identified, plus $238m in securities without a listed ticker
Click a column to sort. Values are as reported at quarter-end, not today's prices.
| # | Stock | Shares | ||||
|---|---|---|---|---|---|---|
| 1 | ORKAORUKA THERAPEUTICS INC | $309m | 3,705,262 | Unchanged | 5 | |
| 2 | KRSAKORSANA BIOSCIENCES INC | $291m | 9,103,729 | New | 5 | |
| 3 | DNTHDIANTHUS THERAPEUTICS INC | $223m | 2,537,191 | Unchanged | 5 | |
| 4 | COGTCOGENT BIOSCIENCES INC | $176m | 5,503,418 | Unchanged | 7 | |
| 5 | VRDNVIRIDIAN THERAPEUTICS INC | $105m | 5,090,928 | Unchanged | 6 | |
| 6 | ELVNENLIVEN THERAPEUTICS INC | $85m | 1,855,644 | Unchanged | 3 | |
| 7 | JBIOJADE BIOSCIENCES INC | $64m | 4,553,494 | Unchanged | 3 | |
| 8 | ZBIOZENAS BIOPHARMA INC | $64m | 2,371,358 | +0.5% | — | |
| 9 | FTHFAETH THERAPEUTICS INC | $21m | 722,020 | Unchanged | 4 | |
| 10 | IKTINHIBIKASE THERAPEUTICS INC | $18m | 8,625,000 | Unchanged | 1 |
Closest portfolios
Overlap is the weight two books have in common: for each shared stock, the smaller of the two weights, summed.
- TCG Crossover Management10.5%3 shared · DNTH, KRSA, COGT
- Paradigm Biocapital Advisors9.6%4 shared · ORKA, VRDN, JBIO, KRSA
- Novo Holdings5.5%2 shared · ELVN, VRDN
- Rtw Investments4.9%5 shared · ORKA, VRDN, COGT, KRSA
- Deerfield Management4.2%2 shared · COGT, DNTH
- Perceptive Advisors2.2%3 shared · ORKA, ELVN, VRDN
- Ra Capital Management2.0%5 shared · ORKA, KRSA, JBIO, IKT
- General Atlantic1.8%1 shared · KRSA
- Montanova Capital1.3%1 shared · FTH
- Avoro Capital Advisors1.0%2 shared · VRDN, FTH
Only here
The largest holdings no other tracked guru owns.
- ZBIOZENAS BIOPHARMA INC4.0%
A 13F is a filing, not a live portfolio. It lists US-listed long stock positions at quarter-end, and it arrives up to 45 days later. Cash, shorts, bonds, options and foreign listings are not in it. Trade sizes here are estimates from the change in share count, restated for stock splits.
Snapshot refreshed